Dulaglutide (Trulicity)

FDA-approved product existsMetabolic ResearchWeight & metabolic

Awaiting review, BioHarmony verdict

Not yet scored. Queued for review; until then rely on the status and sources below.

What is Dulaglutide (Trulicity)?

FDA-approved dulaglutide is marketed as Trulicity for improving glycemic control in adults and children 10 years and older with type 2 diabetes, with additional labeled cardiovascular-risk reduction in adults.

Saved on this device only.

Dosing as published

Source-reported figures only. This page does not calculate a personal dose.

Approved labelTRULICITY prescribing information for type 2 diabetes
PopulationAdults and pediatric patients covered by the approved TRULICITY indication
DoseThe adult starting dose is 0.75 mg once weekly and may be increased according to the label. Pediatric dosing starts at 0.75 mg once weekly and has a separate labeled maximum.
RouteSubcutaneous injection in the abdomen, thigh, or upper arm
FrequencyOnce weekly
DurationLong-term use within the approved indication
PreparationReady-to-use solution in a single-dose pen; no reconstitution.
Source: Dosage and Administration section 2; Dosage Forms and Strengths section 3

Working with a vial? The reconstitution calculator covers mixing math, not dosing advice.

More reported protocols

Members

Members can compare additional reported doses, schedules, and preparation notes.

Trust & sourcing

  1. Last revieweddone
  2. Next reviewupcoming
US approvalFDA-approved product exists
CompoundingFDA-approved product exists; compounded copies are not FDA approved

Primary sources

The Ultimate Peptides Guide

Spot stronger candidates, weak evidence, and seller red flags before you buy.

Free. Includes evidence and regulatory updates. Unsubscribe anytime.